Brändström H et al. |
Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9642127
|
Tsukii K et al. |
Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9610359
|
Emery JG et al. |
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. |
1998 |
J. Biol. Chem. |
pmid:9603945
|
Matsuzaki K et al. |
Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9600092
|
Bucay N et al. |
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. |
1998 |
Genes Dev. |
pmid:9573043
|
Tomoyasu A et al. |
Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9571159
|
Lacey DL et al. |
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. |
1998 |
Cell |
pmid:9568710
|
Yasuda H et al. |
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9520411
|
Yasuda H et al. |
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. |
1998 |
Endocrinology |
pmid:9492069
|
Yamaguchi K et al. |
Characterization of structural domains of human osteoclastogenesis inhibitory factor. |
1998 |
J. Biol. Chem. |
pmid:9478964
|